Redox regulation of β2-integrin CD11b/CD18 activation

European Journal of Immunology

Volumn 29, Issue 11, 1999, Pages 3419-3431

  Blouin, Eric ^a   Halbwachs Mecarelli, Lise ^a   Rieu, Philippe ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

2 integrin; Adhesion; Neutrophil; Oxide reduction; TFN

Indexed keywords

ARSENOSOBENZENE; CD11B ANTIGEN; CD18 ANTIGEN; DIPHENYLIODONIUM SALT; HYDROGEN PEROXIDE; INTEGRIN; MONOCLONAL ANTIBODY; PROTEIN TYROSINE KINASE INHIBITOR; SCAVENGER; THIOL GROUP; TUMOR NECROSIS FACTOR ALPHA; PROTEIN TYROSINE KINASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; THIOL DERIVATIVE;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; LEUKOCYTE ADHERENCE; NEUTROPHIL; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; CELL ADHESION; DRUG ANTAGONISM; METABOLISM; PHYSIOLOGY;

ANTIGENS, CD18; CELL ADHESION; HYDROGEN PEROXIDE; MACROPHAGE-1 ANTIGEN; NADPH OXIDASE; NEUTROPHILS; OXIDATION-REDUCTION; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; SULFHYDRYL COMPOUNDS;

EID: 0032589682     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199911)29:11<3419::AID-IMMU3419>3.0.CO;2-1     Document Type: Article

References (57)

1. Arnaout, M. A., Leukocyte adhesion molecule deficiency: Its structural basis, pathophysiology and implications for modulating the inflammatory response. Immunol. Rev. 1990. 114: 145-180.
2. Berton, G., Yan, S. R., Fumagalli, L. and Lowell, C. A., Neutrophil activation by adhesion: mechanisms and pathophysiological implications. Int. J. Clin. Lab. Res. 1996. 26: 160-177.
3. Lub, M., Van Kooyk, Y. and Figdor, C. G., Ins and outs of LFA-1. Immunol. Today 1995. 16: 479-483.
4. Stewart, M. and Hogg, N., Regulation of leukocyte integrin function: affinity vs. avidity. J. Cell. Biochem. 1996. 61: 554-561.
5. Rieu, P. and Arnaout, M. A., The structural basis and regulation of β2 integrin interactions. In Ward, P. and Fantone, J. C. Eds) Lung biology in Health and Disease. Lenfant, C., New York 1996, vol. 89, pp 1-42.
6. Andrew, D., Shock, A., Ball, E., Ortlepp, S., Bell, J. and Robinson, M., KIM 185, a monoclonal antibody to CD18 which induces a change in the conformation of CD18 and promotes both LFA-1- and CR3-dependent adhesion. Eur. J. Immunol. 1993. 23: 2217-2222.
7. Robinson, M. K., Andrew, D., Rosen, H., Brown, D., Ortlepp, S., Stephens, P. and Butcher, E. C., Antibody against the Leu-CAM β chain (CD18) promotes both LFA1- and CR3-dependent adhesion events. J. Immunol. 1992. 148: 1080-1085.
8. Landis, R. C., Bennett, R. I. and Hogg, N., A novel LFA-1 activation epitope maps to the I domain. J. Cell Biol. 1993. 120: 1519-1527.
9. Lee, J. O., Rieu, P., Arnaout, M. A. and Liddington, R., Crystal structure of the A-domain from the α-subunit of integrin CR3 (CD11b CD18). Cell 1995. 80: 631-638.
10. Lee, J. O., Bankston, L. A., Arnaout, M. A. and Liddington, R. C., Two conformations of the integrin A-domain (I-domain): a pathway for activation. Structure 1995. 3: 1333-1340.
11. Rieu, P., Sugimori, T., Griffith, D. L. and Arnaout, M. A., Solvent accessible residues on the MIDAS face of integrin CR3 mediate its binding to the neutrophil adhesion inhibitor NIF. J. Biol. Chem. 1996. 271: 15853-15861.
12. 2+-complexed crystal structures. J. Cell Biol. 1998. 143: 1523-1534.
13. Altieri, D. C. and Edgington, T. S., A monoclonal antibody reacting with distinct adhesion molecules defines a transition in the functional state of the receptor CD11b/CD18 (Mac-1). J. Immunol. 1988. 141: 2656-2660.
14. Diamond, M. S. and Springer, T. A., A subpopulation of Mac-1 (CD11b/CD18) molecules mediates neutrophil adhesion to ICAM-1 and fibrinogen. J. Cell Biol. 1993. 120: 545-556.
15. Morimoto, C., Rudd, C. E., Letvin, N. L. and Schlossman, S. F., A novel epitope of the LFA-1 antigen which can distinguish killer effector and suppressor cells in human CD8 cells. Nature 1987. 330: 479-482.
16. 2+ binding epitope on leukocyte integrin α subunits. EMBO J. 1989. 8: 3759-3765.
17. Nakamura, H., Nakamura, K. and Yodoi, J., Redox regulation of cellular activation. Annu. Rev. Immunol. 1997. 15: 351-369.
18. Lander, H. M., An essential role for free radicals and derived species in signal transduction. FASEB J. 1997. 11: 118-124.
19. Fialkow, L., Chan, C. K., Grinstein, S. and Downey, G. P., Regulation of tyrasine phosphorylation in neutrophils by NADPH oxidase. J. Biol. Chem. 1993. 268: 17131-17137.
20. Brumell, J. H., Burkhardt, A. L., Bolen, J. B. and Grinstein, S., Endogenous reactive oxygen intermediates activate tyrosine kinases in human neutrophils. J. Biol. Chem. 1996. 271: 1455-1461.
21. Yan, S. R. and Berton, G., Regulation of Src family tyrosine kinase activities in adherent human neutrophils. J. Biol. Chem. 1996. 271: 23464-23471.
22. Coxon, A., Rieu, P., Barkalow, F. J., Askari, S., Sharpe, A. H., von Adian, U. H., Arnaout, M. A. and Mayadas, T. N., A novel role for β2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation. Immunity 1996. 5: 653-666.
23. Bass, D. A., Parce, J. W., Dechatelet, L. R., Szejda, P., Seeds, M. C. and Thomas, M., Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J. Immunol. 1983. 130: 1910-1917.
24. Margoliash, E., Novogrodsky, A. and Schejter, A., Irreversible reaction of 3-amino-1:2:4-triazole and related inhibitors with the protein of catalase. Biochem. J. 1960. 74: 339-348.
25. Shechter, Y., Yaish, P., Chorev, M., Gilon, C., Braun, S. and Levitzki, A., Inhibition of insulin-dependent lipogenesis and anti-lipolysis by protein tyrosine kinase inhibitors. EMBO J. 1989. 8: 1671-1676.
26. Laudana, C., Rossi, F. and Berton, G., Effect of inhibitors of distinct signalling pathway on neutrophil O2-generation in response to tumor necrosis factor-α, and antibodies against CD18 and CD11a: evidence for a common and unique pattern of sensitivity to wortmannin and protein tyrosine inhibitors. Biochem. Biophys. Res. Commun. 1993. 190: 935-940.
27. Webb, J. L., Arsenicals. In Enzyme and metabolic inhibitors, Vol. 3. Academic Press, New York 1966, pp 608-700.
28. Huffman, R. D. and Lane, M. D., lodophenylarsine oxide and arsenical affinity chromatography: new probes for dithiol proteins. Application to tubulins and to components of the insuline receptor-glucose transporter signal transduction pathway. J. Biol. Chem. 1992. 267: 14005-14011.
29. Le Cabec, V. and Maridonneau-Parini, I., Complete and reversible inhibition of NADPH oxidase in human neutrophils by phenylarsine oxide at a step distal to translocation of the enzyme subunits. J. Biol. Chem. 1995. 270: 2067-2073.
30. O'Donnell, V., Tew, D. G., Jones, O. T. G. and England, P. J., Studies on the inhibitory mechanism of iodonium compounds with special reference to neutrophil NADPH oxidase. Biochem. J. 1993. 290: 41-49.
31. Dusi, S., Della Bianca, V., Donini, M., Nadalini, K. A. and Rossi, F., Mechanisms of stimulation of the respiratory burst by TNF in nonadherent neutrophils. J. Immunol. 1996. 157: 4615-4623.
32. Ellis, J. A., Mayer, S. J. and Jones, O. T. G., The effect of the NADPH oxidase inhibitor diphenyleneiodonium on aerobic and anaerobic microbicial activities of human neutrophils. Biochem. J. 1988. 251: 887-891.
33. Fischer, E. H., Charbonneau, H. and Tonks, N. K., Proteins tyrosine phosphatase: a diverse family of intracellular and transmembrane enzymes. Science 1990. 253: 401-406.
34. Bauskin, A. R., Alkalay, I. and Ben-Neriah, Y., Redox regulation of protein tyrosine kinase in the endoplasmic reticulum. Cell 1991. 66: 685-696.
35. Kosower, N. S. and Kosower, E. M., Formation of disulfides with diamide. Methods Enzymol. 1987. 143: 264-270.
36. Moriguchi, T., Seres, T., Ravichandran, V., Sasada, M. and Johnston, R. B., Diamide primes neutrophils for enhanced realease of superoxide anion: relationship to S-thiolation of cellular proteins. J. Leukoc. Biol. 1996. 60: 191-198.
37. Schwartz, B. R. and Harlan, J. M., Sulhydryl reducing agents promote neutrophil adhesion without increasing surface expression of CD11b/Cd18 (Mac-1, Mo1). Biochem. Biophys. Res. Commun. 1989. 30: 51-57.
38. Edwards, B. S., Curry, M. S., Southon, E. A., Chong, A. S. and Graf, L. H., Evidence for a dithiol-activated signaling pathway in natural killer cell avidity regulation of leukocyte function antigen-1: structural requirements and relationship to phorbol ester- and CD16-triggered pathway. Blood 1995. 86: 2288-2301.
39. Zucker, M. B. and Masiello, N. C., Platelet aggregation caused by dithiothreitol. Thromb. Haemost. 1984. 51: 119-122.
40. Ni, H., Li, A., Simonsen, N. and Wilkins, J. A., Integrin activation by dithiothreitol or Mn2+ induces a ligand-occupied conformation and exposure of a novel NH2-terminal regulatory site on the β1 integrin chain. J. Biol. Chem. 1998. 273: 7981-7987.
41. Davis, G. E. and Camarillo, C. W., Regulation of integrin-mediated myeloid cell adhesion to fibronectin: influence of disulfide reducing agents, divalent cations and phorbol ester. J. Immunol. 1993. 151: 7138-7150.
42. Edwards, B. S., Southon, E. A., Curry, M. S., Salazar, F., Gale, J. M., Robinson, M. K., Graf, L. H. and Born, J. L., Oxidant inhibition of αLβ2 integrin adhesion: evidence for coordinate effects on conformation and cytoskeleton linkage. J. Leukoc. Biol. 1998. 63: 190-202.
43. Montoya, M. C., Luscinska, F. W., del Pozo, M. A., Aragones, J. and de Landazuri, M. O., Reduced intracellular oxidative metabolism promotes firm adhesion of human polymorphonuclear leukocytes to vascular endothelium under flow conditions. Eur. J. Immunol. 1997. 27: 1942-1951.
44. 2 for platelet-derived growth factor signal transduction. Science 1995. 270: 296-299.
45. Staal, F. J. T., Roederer, M. and Herzenberg, L. A., Intracellular thiols regulate activation of nuclear factor kB and transcription of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 1990. 87: 9943-9947.
46. Schreck, R., Rieber, P. and Baeuerle, P. A., Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kB transcription factor and HIV-1. EMBO J. 1991. 10: 2247-2258.
47. Doussiere, J. and Vignais, P. V., Diphenylene iodonium as an inhibitor of the NADPH oxidase complex of bovine neutrophils. Factors controlling the inhibitory potency of diphenylene iodonium in a cell-free system of oxidase activation. Eur. J. Biochem. 1992. 208: 61-71.
48. Ragan, C. I. and Bloxham, D., Specific labelling of a constituent polypeptide of bovine heart mitochondrial reduced nicotinamide-adenine dinucleotide-ubiquinone reductase by the inhibitor diphenyleneiodonium. Biochem. J. 1977. 163: 605-615.
49. Cross, A. R. and Jones, O. T. G., Enzymic mechanism of superoxide production. Biochim. Biophys. Acta 1991. 1057: 281-298.
50. Fuortes, M., Jin, W. W. and Nathan, C., Adhesion-dependent protein tyrosine phosphorylation in neutrophils treated with tumor necrosis factor. J. Cell Biol. 1993. 120: 777-784.
51. Rafiee, P., Lee, J. K., Leung, C. C. and Raffin, T. A., TNF-α induces tyrosine phosphorylation of mitogen-activated protein kinase in adherent human neutrophils. J. Immunol. 1995. 154: 4785-4792.
52. Graham, I. L., Anderson, D. C., Holers, M. M. and Brown, E. J., Complement receptor 3 (CR3, Mac-1, Integrin αMβ2, CD11b/CD18) is required for tyrosine phosphorylation of paxillin in adherent and non adherent neutrophils. J. Cell Biol. 1994. 17: 1139-1147.
53. Fuortes, M., Jin, W. W. and Nathan, C., β2-integrin-dependent tyrosine phosphorylation of paxillin in human neutrophils treated with tumor necrosis factor. J. Cell Biol. 1994. 127: 1477-1483.
54. Berton, G., Fumagalli, L., Laudanna, C. and Sorio, C., β2 integrin-dependent protein tyrosine phosphorylation and activation of the FGR protein tyrosine kinase in human neutrophils. J. Cell Biol. 1994. 126: 1111 -1121.
55. c-fgr results in defective adhesion-dependent neutrophil functions. J. Cell Biol. 1996. 133: 895-910.
56. Hupa, J. B. and Ploegh, H. L., The eS-Sence of -SH in the ER. Cell 1998. 92: 145-148.
57. Rieu, P., Porteu, F., Bessou, G., Lesavre, P. and Halbwachs-Mecarelli, L., Human neutrophils release their major membrane sialoprotein, leukosialin (CD43), during cell activation. Eur. J. Immunol. 1992. 22: 3021-3026.